Hartford Dispensary: Medical-Director Certifications Behind Opioid Treatment Claims

In the Hartford Dispensary fraud case, the provider agreed to a $627,000 settlement over allegations that it falsely certified an opioid-treatment medical director was performing required duties, supporting Medicaid claims. The question for clinic insiders is concrete: did the work behind the certification match what Medicaid was told? Someone who knew both the paperwork and the daily operation could see the difference.

Two former employees brought the federal and state False Claims Act case. The defendants included Hartford Dispensary, Hartford Dispensary Endowment Corporation and the provider’s former president and chief executive.

How the Certifications Reached Medicaid Claims

The government alleged that Hartford falsely represented its medical director was performing required duties from January 1, 2009 through November 20, 2015. Whether that work happened mattered to Medicaid payment.

A billing employee may see a completed certification, while clinical staff see who actually participates in treatment and oversight. Hartford’s case put that gap at the center of the payment allegation. An insider’s knowledge of how clinical information reached management can be as useful as knowledge of how a claim reached Medicaid.

What the Whistleblowers Alleged Inside Hartford

The medical-director certifications were the government’s stated settlement allegation. The whistleblowers’ complaint also described internal audits, billing problems and decisions about returning money.

According to the complaint, internal audits found missing master treatment plans, missing treatment-plan reviews and missing progress notes. The whistleblowers alleged that 284 of 708 chart audits contained errors that could potentially void a paid claim. These were documents supporting the treatment represented in the bill, and the complaint alleged that the problems had become known to management.

The complaint also described a billing practice Hartford allegedly stopped without returning earlier payments. The whistleblowers said the provider stopped billing Medicaid for off-site services in January 2012 but did not repay past overpayments at that time. Stopping the billing left a separate question: what happened to the money already received?

The complaint alleged a deliberate choice about repayment. The whistleblowers claimed that the chief executive expected an audit to be unlikely and its financial consequences negotiable:

We see a revealing calculation in that allegation. Management allegedly knew about payment problems, yet the prospect of bargaining over an audit became a reason to keep the money. Negotiate later.

The Endowment Corporation and the Money Trail

The same complaint alleged that Hartford Dispensary transferred substantial excess operating funds to its endowment corporation annually. The whistleblowers connected those transfers to Medicaid revenue and alleged that part of the endowment’s assets came from services improperly documented or never provided.

Clinical records describe the work represented to Medicaid. Financial records can show where the resulting money went. We follow both. The provider’s treatment operation and the entity receiving its surplus answer different parts of the same inquiry.

The Opioid Treatment Program Payment Rule Matters

The Substance Abuse and Mental Health Services Administration’s program requirements describe the certification and accreditation side. Medicaid enrollment and payment rules address the reimbursement relationship.

For Hartford, the relevant allegation was that a representation about medical-director performance mattered to Medicaid payment. We connect that representation to the requirements governing the particular service period.

A separate opioid-treatment case shows why the payment terms deserve that attention. In the APT Foundation settlement announced in December 2017, the government alleged that Medicaid’s weekly methadone payments already included onsite drug testing, while an outside laboratory also billed Medicaid for testing referred by APT.

APT’s allegation concerned testing already included in a payment. Hartford’s concerned required medical-director work represented as performed. Both make the payer’s actual terms essential to understanding the claim.

When the Medical Director Exists on Paper

Other behavioral health complaints describe a similar gap between a medical-director title and the work behind it. In a complaint against Oglethorpe, whistleblowers alleged that Georgetown Behavioral Hospital listed a physician from another facility as medical director despite his limited presence and lack of oversight:

The shared issue is the work represented by the clinical title. Oglethorpe’s whistleblowers alleged that a physician’s signatures supplied the appearance of oversight. Hartford’s settlement concerned allegations that required medical-director duties were falsely certified as performed. For an employee who sees the actual staffing and supervision, that difference between the clinical operation and its paperwork can be visible long before it appears in a payment dispute.

What Evidence Is Needed to Prove Fraud?

Proving a medical-director certification case takes connecting what the clinic did with what it told Medicaid. We work through that with you, including what management knew and how it responded. Hartford’s complaint supplies a concrete example: internal audits identifying missing documents, followed by an alleged decision about whether to return payments.

Different employees can recognize different parts of that chain. Clinical staff know the work and oversight they experienced. Billing staff know what the organization represented for payment. People involved in internal review may know which discrepancies reached management and what happened next. We bring those accounts together to assess the strongest healthcare whistleblower case the evidence supports.

How Much of a Settlement Does a Whistleblower Get?

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

The Hartford resolution, announced September 7, 2017, identified a collective whistleblower reward for the two former employees who brought the case.

You Know the Work Behind the Certification

If you saw medical-director certifications that did not match the clinic’s work, or audit findings that management set aside, talk with our whistleblower experts about what happened. We build the case with you around the clinical representation, the Medicaid payments and the decisions inside the provider, and bring in health care fraud whistleblower lawyers who understand treatment-program billing. We stay beside you through the case, with your knowledge of the operation at its center.